Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
95.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.80 (0.833%)
Market Cap: £580.22m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Syncona News

Syncona focuses short-term cash on more conservative investments
12 Mar 2019

Syncona focuses short-term cash on more conservative investments

(Sharecast News) - Healthcare firm Syncona plans to focus its investment strategy more towards conservative investments like cash and bonds moving for...

WINNERS & LOSERS SUMMARY: DMGT Rises, Euromoney Falls On Share Return
4 Mar 2019

WINNERS & LOSERS SUMMARY: DMGT Rises, Euromoney Falls On Share Return

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday:----------FTSE 100 - up 4.2%...

Syncona To Gain GBP255 Million From Nightstar Acquisition By Biogen
4 Mar 2019

Syncona To Gain GBP255 Million From Nightstar Acquisition By Biogen

LONDON (Alliance News) - Syncona Ltd on Monday said investee company Nightsar Therapeutics PLC has agreed to be acquired by neuroscience healthcare fi...

Syncona to cash in as Biogen acquires Nightstar
4 Mar 2019

Syncona to cash in as Biogen acquires Nightstar

(Sharecast News) - Healthcare investment company Syncona updated the market on Nightstar Therapeutics on Monday, confirming it has reached an agreemen...

Syncona pours £21m into immuno-oncology company Anaveon
26 Feb 2019

Syncona pours £21m into immuno-oncology company Anaveon

(Sharecast News) - Syncona announced a CHF 28m (£21.4m) commitment to Anaveon, a new immuno-oncology company, in a CHF 35m Series A financing on Tuesd...

Syncona close to injecting funds in new prospects
13 Feb 2019

Syncona close to injecting funds in new prospects

(Sharecast News) - Syncona, the healthcare investor, said it was in the "final stages" of agreeing funding for two new companies, though its net asset...

Syncona's Autolus Therapeutics Reports Progress On Therapy Development
3 Dec 2018

Syncona's Autolus Therapeutics Reports Progress On Therapy Development

LONDON (Alliance News) - FTSE 250-listed healthcare-focused investor Syncona Ltd on Monday reported on progress made by portfolio company, Nasdaq-list...

Autolus reports early progress with cancer drugs
3 Dec 2018

Autolus reports early progress with cancer drugs

(Sharecast News) - Autolus Therapeutics reported progress in clinical trials for one of its cancer treatments and said it has begun dosing patients in...